We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Atara Biotherapeutics
ATRA
$76.1M
| $5.99M | ﹤0.01% |
16,451
+229
| +1% | +$57.8K |
|
1802
PTC Therapeutics
PTCT
$6.12B
| $5.97M | ﹤0.01% |
287,866
-254,368
| -47% | -$12.5M |
|
1803
Johnson Outdoors
JOUT
$505M
| $5.96M | ﹤0.01% |
65,505
+3,226
| +5% | +$231K |
|
|
HSII
1804
DELISTED
Heidrick & Struggles
HSII
| $5.93M | ﹤0.01% |
274,504
-46,891
| -15% | -$1.03M |
|
1805
Hyatt Hotels
H
$16.7B
| $5.92M | ﹤0.01% |
117,799
-80,116
| -40% | -$4.27M |
|
1806
Murphy Oil
MUR
$4.78B
| $5.92M | ﹤0.01% |
429,368
+87,342
| +26% | +$1M |
|
|
SWAV
1807
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.89M | ﹤0.01% |
124,410
+35,034
| +39% | +$1.44M |
|
1808
Tower Semiconductor
TSEM
$28.5B
| $5.89M | ﹤0.01% |
308,360
-86,204
| -22% | -$1.65M |
|
1809
AngioDynamics
ANGO
$649M
| $5.88M | ﹤0.01% |
578,497
+10,328
| +2% | +$106K |
|
|
CBB
1810
DELISTED
Cincinnati Bell Inc.
CBB
| $5.87M | ﹤0.01% |
395,543
-110,192
| -22% | -$1.63M |
|
1811
Super Micro Computer
SMCI
$20.1B
| $5.86M | ﹤0.01% |
+2,064,040
| New | +$5.2M |
|
|
MRC
1812
DELISTED
MRC Global
MRC
| $5.85M | ﹤0.01% |
989,660
+343,619
| +53% | +$1.79M |
|
|
POLY
1813
DELISTED
Plantronics, Inc.
POLY
| $5.83M | ﹤0.01% |
397,387
+246,627
| +164% | +$3.22M |
|
1814
Stock Yards Bancorp
SYBT
$2.6B
| $5.82M | ﹤0.01% |
144,718
-3,365
| -2% | -$110K |
|
1815
Belden
BDC
$5.19B
| $5.81M | ﹤0.01% |
178,602
+9,450
| +6% | +$314K |
|
1816
MacroGenics
MGNX
$257M
| $5.81M | ﹤0.01% |
764,795
-126,760
| -14% | -$2.2M |
|
1817
Myers Industries
MYE
$1.29B
| $5.8M | ﹤0.01% |
398,893
-52,042
| -12% | -$646K |
|
1818
Sphere Entertainment
SPHR
$5.73B
| $5.8M | ﹤0.01% |
+77,324
| New | +$5.94M |
|
1819
Apple Hospitality REIT
APLE
$3.82B
| $5.79M | ﹤0.01% |
599,702
-25,869
| -4% | -$246K |
|
1820
Brookfield Infrastructure
BIPC
$4.85B
| $5.79M | ﹤0.01% |
+190,787
| New | +$5.54M |
|
1821
Cushman & Wakefield Ltd
CWK
$3.25B
| $5.76M | ﹤0.01% |
462,458
-5,816
| -1% | -$65.5K |
|
1822
Vicor
VICR
$10.2B
| $5.75M | ﹤0.01% |
79,902
-621
| -0.8% | -$34.9K |
|
1823
Impinj
PI
$5.6B
| $5.74M | ﹤0.01% |
208,929
-196,395
| -48% | -$4.6M |
|
|
SC
1824
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $5.74M | ﹤0.01% |
311,522
-66,464
| -18% | -$1.08M |
|
|
PING
1825
DELISTED
Ping Identity Holding Corp.
PING
| $5.72M | ﹤0.01% |
178,383
+127,667
| +252% | +$3.38M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.